Rizwan Ishtiaq, Arslan Naeem, Iqbal Ratnani


Liposarcoma arising in the thoracic cavity is a rare entity. It is usually found in the retroperitoneal space and the extremities. No case of thoracic liposarcoma in a patient suffering from the end-stage renal disease has been reported in the literature. We herein present the first case of thoracic liposarcoma in a patient suffering from the end-stage renal disease. Metabolic disturbances, increased use of erythropoietin and increased diagnostic workup attributes to greater risk of cancer in patients suffering from renal failure. A chemotherapeutic drug, Trabectedin has been approved for advanced liposarcoma. Prognosis of such tumours depends on the size, location, and their histological subtype.

Keyword: End-stage renal disease, Erythropoietin, Liposarcoma, Thoracic cavity, Trabectedin

Full Text:



Angarita FA, Cannell AJ, Razak AR, Dickson BC, Blackstein ME. Trabectedin for inoperable or recurrent soft tissue sarcoma in adult patients: a retrospective cohort study. BMC Cancer 2016;16(1):30.

Chou CK, Chen ST. Computed tomography identification of an exophytic colonic liposarcoma. Radiol Case Rep 2016;11(3):161–4.

Coindre JM, Pédeutour F, Aurias A. Well-differentiated and dedifferentiated liposarcomas. Virchows Arch 2010;456(2):167–79.

Wyatt SH, Fishman EK, Hruban RH, Siegelman SS. CT of primary colonic lymphoma. Clin Imaging 1994;18(2):131–41.

Ghosh P, Saha K. A rare case of primary anterior chest wall pleomorphic liposarcoma. Saudi J Health Sci 2014;3(2):121–3.

Henze J, Bauer S. Liposarcomas. Hematol Oncol Clin North Am 2013;27(5):939–55.

Butler AM, Olshan AF, Kshirsagar AV, Edwards JK, Nielsen ME, Wheeler SB, et al. Cancer incidence among US Medicare ESRD patients receiving hemodialysis, 1996-2009. Am J Kidney Dis 2015;65(5):763–72.

Kasiske BL, Ramos EL, Gaston RS, Bia MJ, Danovitch GM, Bowen PA, et al. The evaluation of renal transplant candidates: clinical practice guidelines. Patient Care and Education Committee of the American Society of Transplant Physicians. J Am Soc Nephrol 1995;6(1):1–34.

Vajdic CM, McDonald SP, McCredie MR, van Leeuwen MT, Stewart JH, Law M, et al. Cancer incidence before and after kidney transplantation. JAMA 2006;296(23):2823–31.

Szenajch J, Wcislo G, Jeong JY, Szczylik C, Feldman L. The role of erythropoietin and its receptor in growth, survival and therapeutic response of human tumor cells: from clinic to bench - a critical review. Biochim Biophys Acta 2010;1806(1):82–95.

Mentzel T. Biological continuum of benign, atypical, and malignant mesenchymal neoplasms - does it exist? J Pathol 2000;190(5):523–5.

Fujimoto R, Sato M, Miyata R, Minakata K, Omasa M, Kubo T, et al. Successful resection of recurrent mediastinal liposarcoma using preoperative evaluation of organ invasion by four-dimensional computed tomography. Gen Thorac Cardiovasc Surg 2016;64(8):488–91.

Seo JS, Kim YJ, Choi BW, Choe KO. Usefulness of magnetic resonance imaging for evaluation of cardiovascular invasion: evaluation of sliding motion between thoracic mass and adjacent structures on cine MR images. J Magn Reson Imaging 2005;22(2):234–41.

Gemici K, Buldu İ, Acar T, Alptekin H, Kaynar M, Tekinarslan E, et al. Management of patients with retroperitoneal tumors and a review of the literature. World J Surg Oncol 2015;13(1):143.

D'Incalci M, Galmarini CM. A review of trabectedin (ET-743): a unique mechanism of action. Mol Cancer Ther 2010;9(8):2157–63.

Thariat J, Etienne-Grimaldi MC, Launay-Vacher V, Soto-Matos A, Fernandez-Teruel C, Ghafari T, et al. Pharmacokinetics of trabectedin on hemodialysis: an application for the management of cancer patients with end-stage renal disease. Cancer Chemother Pharmacol 2011;68(5):1363–7.


  • There are currently no refbacks.

Contact Number: +92-992-382571

email: [jamc] [@] []